science

Narsoplimab

Narsoplimab is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Narsoplimab rather than just read about it. In short: Narsoplimab, sold under the brand name Yartemlea, is a monoclonal antibody used for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy. Narsoplimab is a mannan-binding lectin-associated serine protease-2 (MASP-2) inhibitor.

Key takeaways

Narsoplimab belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Narsoplimab to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Narsoplimab from memory before moving on to harder problems.

Reference excerpt

Narsoplimab, sold under the brand name Yartemlea, is a monoclonal antibody used for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy. Narsoplimab is a mannan-binding lectin-associated serine protease-2 (MASP-2) inhibitor. It is a recombinant human immunoglobulin G4 (IgG4) monoclonal antibody. Narsoplimab was approved for medical use in the United States in December 2025. The US Food and Drug Administration considers it to be a first-in-class medication.

Medical uses Narsoplimab is indicated for the treatment of people with hematopoietic stem cell transplant-associated thrombotic microangiopathy. Hematopoietic stem cell transplant-associated thrombotic microangiopathy is a serious and life-threatening complication of hematopoietic stem cell transplant in which tiny blood clots form in the small blood vessels. This can lead to organ damage, including damage to the kidneys, cardiovascular system, and gastrointestinal tract.

Side effects The most common side effects are viral infections, sepsis, hemorrhage, diarrhea, vomiting, nausea, neutropenia (low number of neutrophils, a type of white blood cell), fever, fatigue, and low potassium.

Mechanism of action Thrombotic microangiopathy is triggered by immunosuppressive treatment during stem cell transplant, especially when calcineurin and mTOR inhibitors are used. It causes injury to endothelial cells, which is associated with an alteration of carbohydrate patterns on these cells, which is recognized by the complement system in the lectin pathway. Lectins are proteins that recognize specific glycoproteins, which is the main cause of microangiopathy during and after this procedure. Mannan-binding lectin-associated serine protease-2 (MASP-2) directly induces the coagulation cascade and the activation of C4 and C2 components. However, it can also bypass their activation by directly activating the C3 component, causing further activation of the terminal pathway and opsonization. Narsoplimab blocks the action of MASP-2.

History The efficacy of narsoplimab was assessed in a single-arm, open-label study (TA-TMA Study) of 28 participants, with additional data from 19 participants (6 pediatric participants and 13 adult participants) enrolled in an expanded access program. In the TA-TMA Study, participants either received narsoplimab 4 mg/kg or 370 mg intravenously once weekly.

Society and culture

Legal status The European Medicines Agency has recommended the refusal of the marketing authorization for Yartemlea, a medicine intended for the treatment of people from two years of age with hematopoietic stem cell transplant-associated thrombotic microangiopathy. The company for Yartemlea has requested a re-examination of EMA's opinion. Upon receipt of the grounds of this request, the Agency will re-examine its opinion and issue a final recommendation.

Names Narsoplimab is the international nonproprietary name. Narsoplimab is sold under the brand name Yartemlea.

References

Worked examples

Example 1 — a first encounter with Narsoplimab

Start with the simplest possible case. Write down what Narsoplimab claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Narsoplimab before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Narsoplimab ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Narsoplimab

In research: Narsoplimab appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Narsoplimab in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Narsoplimab is common in secondary-school and first-year university syllabi. It links to neighbouring topics Anti-inflammatory agents, Drugs not assigned an ATC code, Monoclonal antibodies, so understanding it makes those chapters shorter.
In everyday life: Look for Narsoplimab outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Narsoplimab” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Narsoplimab in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Narsoplimab means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Narsoplimab out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Narsoplimab in simple terms?

Why does Narsoplimab matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Narsoplimab?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Narsoplimab.